Moderna, Inc. logo MRNA - Moderna, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 7
HOLD 16
SELL 4
STRONG
SELL
0
| PRICE TARGET: $40.29 DETAILS
HIGH: $49.00
LOW: $33.00
MEDIAN: $38.00
CONSENSUS: $40.29
DOWNSIDE: 15.48%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue 1,944 3,199 6,848 18,875 17,736 803.4 60.2 135.1 205.8 108.4
Cost of Revenue 868 1,464 4,693 5,416 2,617 39.2 31.0 24.9 20.5 15.1
Gross Profit 1,076 1,735 2,155 13,459 15,119 764.2 29.2 110.2 185.3 93.3
Operating Expenses
R&D Expenses 3,132 4,543 4,845 3,295 1,991 1,370.3 496.3 454.1 410.5 274.7
SG&A Expenses 1,018 1,174 1,549 1,132 567 188.3 109.6 94.3 64.7 57.5
Other Expenses 0 (37) 0 (388) (735) (31.3) (31.0) (454.1) (20.5) (15.1)
Operating Expenses 4,150 5,680 6,394 4,039 1,823 1,527.4 574.9 94.3 454.6 317.1
Operating Income
Operating Income (3,074) (3,945) (4,239) 9,420 13,296 (763.1) (545.7) (468.9) (269.4) (223.8)
Interest Expense 0 24 38 29 18 9.9 6.6 3.1 0.1 0
Interest Income 314 425 421 200 18 24.7 38.5 27.0 15.2 11.3
Profitability
EBITDA (2,553) (3,394) (3,283) 9,768 13,528 (703.4) (477.1) (412.1) (235.3) (208.7)
EBIT (2,768) (3,583) (3,904) 9,420 13,296 (734.6) (508.1) (436.9) (255.9) (223.8)
Income Before Tax (2,768) (3,607) (3,942) 9,575 13,285 (744.5) (514.7) (440.0) (256.0) (215.2)
Income Tax Expense 54 (46) 772 1,213 1,083 2.6 (0.7) 0.3 (0.1) 1.0
Net Income (2,822) (3,561) (4,714) 8,362 12,202 (747.1) (514.0) (384.7) (255.9) (216.2)
Per Share Data
EPS (Basic) -7.26 -9.27 -12.34 21.26 30.31 -1.96 -1.55 -1.17 -0.72 -3.79
EPS (Diluted) -7.26 -9.27 -12.34 20.10 28.29 -1.96 -1.55 -1.17 -0.72 -3.79
Shares Outstanding 389 384 382 394 403 381.3 330.8 328.8 376 64.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 2,595 1,927 2,907 3,205 6,848 2,624 235.9 658.4 134.9 50.1
Short-Term Investments 3,204 5,098 5,697 6,697 3,879 1,984 867.1 863.1 621.2 1,008.1
Net Receivables 184 592 1,081 1,685 3,323 1,408 16.3 30.6 18.4 18.0
Inventory 153 117 202 949 1,441 47 0 0 0 0
Other Current Assets 408 58 88 44 26 11 1.0 0.6 1.0 0
Total Current Assets 6,544 8,099 10,325 13,431 16,071 6,298 1,128.8 1,563.0 783.2 1,087.2
Non-Current Assets
Property, Plant & Equipment 2,853 2,955 2,658 2,139 1,383 387 287.9 212.0 139.0 81.2
Goodwill 0 52 52 0 0 0 0 0 0 0
Intangible Assets 0 40 44 0 0 0 0 0 0 0
Long-Term Investments 2,336 2,508 4,743 8,360 6,843 639 160.0 173.0 145.9 236.6
Other Non-Current Assets 605 407 523 946 46 13 12.7 14.2 16.4 12.2
Total Non-Current Assets 5,794 6,043 8,101 12,427 8,598 1,039 460.6 399.1 301.3 330.0
Total Assets 12,338 14,142 18,426 25,858 24,669 7,337 1,589.4 1,962.1 1,084.5 1,417.2
Current Liabilities
Account Payables 317 405 520 487 302 18 7.1 31.2 20.7 28.2
Short-Term Debt 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 99 153 568 2,038 6,253 3,867 63.3 109.1 96.7 107.7
Other Current Liabilities 1,571 863 842 243 140 99 32.5 26.9 19.5 13.5
Total Current Liabilities 1,987 2,206 3,015 4,923 9,128 4,389 143.1 222.8 191.5 162.8
Non-Current Liabilities
Long-Term Debt 1,243 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities (368) 267 256 135 76 3 0.1 10.3 9.1 5.8
Total Non-Current Liabilities 1,701 1,035 1,557 1,812 1,396 387 271.5 209.1 267.7 412.5
Total Liabilities 3,688 3,241 4,572 6,735 10,524 4,776 414.6 431.9 459.2 575.3
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0.0 0.0 0.0 0.0
Retained Earnings 7,223 10,045 13,606 18,320 9,958 (2,244) (1,496.5) (1,006.6) (621.9) (365.7)
Accumulated Other Comprehensive Income 45 (10) (123) (370) (24) 3 1.8 (1.3) (1.2) (0.4)
Total Stockholders' Equity 8,650 10,901 13,854 19,123 14,145 2,561 1,174.8 1,530.2 625.3 841.9
Total Liabilities & Equity 12,338 14,142 18,426 25,858 24,669 7,337 1,589.4 1,962.1 1,084.5 1,417.2
Debt Metrics
Total Debt 1,916 747 1,243 1,200 916 237 132.4 33.5 15.7 12.5
Net Debt (679) (1,180) (1,664) (2,005) (5,932) (2,387) (103.5) (624.9) (119.2) (37.6)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (2,822) (3,561) (4,714) 8,362 12,202 (747.1) (514.0) (384.7) (255.9) (216.2)
Depreciation & Amortization 215 189 621 348 232 93 31.0 24.9 20.5 15.1
Stock-Based Compensation 483 429 305 226 142 93 81.1 72.6 40.1 39.4
Change in Working Capital 254 (78) (139) (3,455) 1,308 2,577.1 (53.7) (42.6) (137.2) 226.0
Other Non-Cash Items (3) 17 (19) 59 54 0.6 (3.4) (1.0) 1.1 2.2
Operating Cash Flow (1,873) (3,004) (3,118) 4,981 13,620 2,027.0 (459.0) (330.9) (331.5) 66.7
Investing Activities
Capital Expenditure (192) (1,051) (707) (400) (284) (67.4) (31.6) (105.8) (58.4) (33.1)
Acquisitions 0 0 (85) 0 0 0 0 0 0 0
Purchases of Investments (5,768) (6,529) (3,783) (11,435) (12,652) (2,956.3) (1,145.2) (1,227.7) (727.2) (1,415.5)
Sales/Maturities of Investments 7,916 9,529 8,781 6,699 4,443 1,351.8 1,161.8 960.4 1,203.0 808.9
Other Investing Activities (10) 0 0 (40) (30) 0 0 0.6 (1.3) (8.9)
Investing Cash Flow 1,946 1,949 4,206 (5,176) (8,523) (1,671.9) (14.9) (372.5) 416.1 (648.6)
Financing Activities
Net Debt Issuance 539 (10) (270) (184) (140) (6) 1 9.5 1.4 0
Stock Repurchased 0 0 (1,153) (3,329) (857) 0 2.9 (8.2) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 (1.5) (0.6)
Other Financing Activities 19 0 0 0 0 0.2 (0.0) 0 0 0.0
Financing Cash Flow 593 56 (1,377) (3,448) (873) 2,033.2 51.1 1,226.8 0.2 472.9
Cash Position
Net Change in Cash 668 (999) (289) (3,643) 4,224 2,388.2 (422.8) 523.5 84.8 (109.0)
Cash at Beginning 1,929 2,928 3,217 6,860 2,636 247.7 670.5 134.9 50.1 159.0
Cash at End 2,597 1,929 2,928 3,217 6,860 2,635.9 247.7 658.4 134.9 50.1
Free Cash Flow (2,065) (4,055) (3,825) 4,581 13,336 1,959.5 (490.5) (436.6) (389.9) 33.6
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Income Statement
Revenue 1,944 3,199 6,848 18,875 17,736 803.4 60.2 135.1 205.8 108.4
Gross Profit 1,076 1,735 2,155 13,459 15,119 764.2 29.2 110.2 185.3 93.3
Operating Income (3,074) (3,945) (4,239) 9,420 13,296 (763.1) (545.7) (468.9) (269.4) (223.8)
Net Income (2,822) (3,561) (4,714) 8,362 12,202 (747.1) (514.0) (384.7) (255.9) (216.2)
EPS (Diluted) -7.26 -9.27 -12.34 20.10 28.29 -1.96 -1.55 -1.17 -0.72 -3.79
Balance Sheet
Cash & Equivalents 2,595 1,927 2,907 3,205 6,848 2,624 235.9 658.4 134.9 50.1
Total Assets 12,338 14,142 18,426 25,858 24,669 7,337 1,589.4 1,962.1 1,084.5 1,417.2
Total Debt 1,916 747 1,243 1,200 916 237 132.4 33.5 15.7 12.5
Stockholders' Equity 8,650 10,901 13,854 19,123 14,145 2,561 1,174.8 1,530.2 625.3 841.9
Cash Flow
Operating Cash Flow (1,873) (3,004) (3,118) 4,981 13,620 2,027.0 (459.0) (330.9) (331.5) 66.7
Capital Expenditure (192) (1,051) (707) (400) (284) (67.4) (31.6) (105.8) (58.4) (33.1)
Free Cash Flow (2,065) (4,055) (3,825) 4,581 13,336 1,959.5 (490.5) (436.6) (389.9) 33.6